TY - JOUR
T1 - Enhancement of ultrasound reflectivity depends on the specific perfluorocarbons utilized to formulate nanoparticle emulsion contrast agents
AU - Marsh, Jon N.
AU - Hall, Christopher S.
AU - Scott, Michael J.
AU - Fuhrhop, Ralph J.
AU - Gaffney, Patrick J.
AU - Wickline, Samuel A.
AU - Lanza, Gregory M.
N1 - Copyright:
Copyright 2004 Elsevier Science B.V., Amsterdam. All rights reserved.
PY - 2000
Y1 - 2000
N2 - A nongaseous, ligand-targeted perfluorocarbon nanoparticle emulsion has been developed which can acoustically enhance the presence of molecular epitopes on tissue surfaces. We demonstrate the impact of incorporating perfluorocarbons with specific phase velocities into the emulsions on the acoustic reflectivity of plasma clots targeted using these nanoparticles. Porcine plasma clots were targeted in vitro with specific perfluorocarbon emulsions using anti-fibrin antibody solution (NIB 5F3). Five perfluorocarbons were investigated: perfluorohexane, perfluorooctyl-bromide, perfluorooctane, perfluorodichlorooctane, and perfluorodecalin. Ultrasonic backscatter (17-35 MHz) was measured at the front surface of the clots. Backscatter enhancement was determined by comparison with untreated clots. The magnitude of enhancement depended on the perfluorocarbon emulsion used. Perfluorohexane and perfluorooctane exhibited the greatest enhancement relative to untreated clots (23 dB) and perfluorodecalin the least (18 dB), consistent with predictions from a simple acoustic transmission-line model. We conclude that targeted, nongaseous perfluorocarbon contrast agents can significantly increase the sensitivity of ultrasonic detection of low-scattering biological media, and that further optimization of these contrast agents can be realized by judicious choice of the emulsified perfluorocarbon.
AB - A nongaseous, ligand-targeted perfluorocarbon nanoparticle emulsion has been developed which can acoustically enhance the presence of molecular epitopes on tissue surfaces. We demonstrate the impact of incorporating perfluorocarbons with specific phase velocities into the emulsions on the acoustic reflectivity of plasma clots targeted using these nanoparticles. Porcine plasma clots were targeted in vitro with specific perfluorocarbon emulsions using anti-fibrin antibody solution (NIB 5F3). Five perfluorocarbons were investigated: perfluorohexane, perfluorooctyl-bromide, perfluorooctane, perfluorodichlorooctane, and perfluorodecalin. Ultrasonic backscatter (17-35 MHz) was measured at the front surface of the clots. Backscatter enhancement was determined by comparison with untreated clots. The magnitude of enhancement depended on the perfluorocarbon emulsion used. Perfluorohexane and perfluorooctane exhibited the greatest enhancement relative to untreated clots (23 dB) and perfluorodecalin the least (18 dB), consistent with predictions from a simple acoustic transmission-line model. We conclude that targeted, nongaseous perfluorocarbon contrast agents can significantly increase the sensitivity of ultrasonic detection of low-scattering biological media, and that further optimization of these contrast agents can be realized by judicious choice of the emulsified perfluorocarbon.
UR - http://www.scopus.com/inward/record.url?scp=0033747077&partnerID=8YFLogxK
M3 - Conference article
AN - SCOPUS:0033747077
SN - 0277-786X
VL - 3982
SP - 333
EP - 340
JO - Proceedings of SPIE - The International Society for Optical Engineering
JF - Proceedings of SPIE - The International Society for Optical Engineering
T2 - Medical Imaging 2000: Ultrasonic Imaging and Signal Processing
Y2 - 16 February 2000 through 17 February 2000
ER -